- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Health Bulletin 29/ February/ 2024 - Video
Overview
Here are the top health news for the day:
Tata Institute develops Rs 100 tablet to prevent cancer recurrence
The tablet developed by Tata Memorial Centre (TMC) for preventing cancer recurrence is a significant breakthrough in cancer research and treatment. It offers a potentially affordable solution to a critical aspect of cancer management. However, its availability to the public hinges on the approval process from the Food Safety and Standards Authority of India (FSSAI).
According to the information provided, the tablet is currently awaiting approval from FSSAI. The scientists from Tata Institute of Fundamental Research (TIFR) have applied for approval, indicating a proactive step towards making the tablet accessible to the public. Once FSSAI grants approval, the tablet is expected to be available in the market by June-July.
Doctors working in Delhi to mandatorily register with Delhi Medical Council
The Delhi High Court recently upheld the Delhi Medical Council (DMC) notice making it mandatory for the allopathy doctors practicing in Delhi to register with the Council.